Neuropsychiatric masquerades: Distinguishing neurodegenerative disease from bipolar disorder

Qin Xiang Ng^{1

2}, Christl Suet Kwan Yong^{1

2}, Joyce Wei Xin Chong², Kuan Tsee Chee²

Affiliations

Comment

Qin Xiang Ng et al. Bipolar Disord. 2020 Nov.

. 2020 Nov;22(7):761-763.

doi: 10.1111/bdi.12984. Epub 2020 Aug 28.

Qin Xiang Ng^{1

2}, Christl Suet Kwan Yong^{1

2}, Joyce Wei Xin Chong², Kuan Tsee Chee²

No abstract available

Comment on

The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease.
Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. Woolley JD, et al. J Clin Psychiatry. 2011 Feb;72(2):126-33. doi: 10.4088/JCP.10m06382oli. J Clin Psychiatry. 2011. PMID: 21382304 Free PMC article.

1. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):126.
1. Bang J, Spina S, Miller BL. Frontotemporal dementia. The Lancet. 2015;386(10004):1672-1682.
1. Chow TW, Binns MA, Freedman M, et al. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord. 2008;22(4):327-335.
1. Garcin B, Lillo P, Hornberger M, et al. Determinants of survival in behavioral variant frontotemporal dementia. Neurology. 2009;73(20):1656-1661.
1. Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. Eur Neurol. 2003;49(1):13-19.